| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |